Archive Copy: Army Biological Defense Strategy

Abstract

In the summer of 2020, having witnessed the impact of the coronavirus disease 2019 (COVID-19) pandemic, the Army recognized its need for a biological defense strategy that addressed the challenges to readiness and operations from biological warfare and naturally occurring disease outbreaks. Inspired by the more than 25-year relationship between the Army Office of the Surgeon General (OTSG) and the Institute for Defense Analyses (IDA), the Army asked IDA to develop the Army Biological Defense Strategy (ABDS) and adjudicate Army-wide review comments in coordination with Army stakeholders. The ABDS was signed by the Deputy Chief of Staff, G-3/5/7 in March 2021. This paper is the record of the final version of the ABDS delivered by IDA to the Army. It is an unsigned and unofficial version of the ABDS.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 2021
Accession Number
AD1165600

Entities

People

  • Douglas P. Schultz
  • Jeffrey H. Grotte
  • Julia K. Burr
  • Sean M. Oxford

Organizations

  • Institute for Defense Analyses

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Asymmetric Warfare
  • Biological Sciences
  • Biological Warfare
  • Biological Weapons
  • Casualties
  • Chemical Biological Radiological And Nuclear Defense
  • Command And Control
  • Covid-19
  • Disease Outbreaks
  • Health Services
  • Hygiene
  • Infectious Diseases
  • Lessons Learned
  • Medical Personnel
  • Military Science
  • Multi-Domain Operations
  • Public Health
  • Quarantine
  • Therapy
  • United States
  • Warfare

Readers

  • Defense Acquisition Program Management
  • Infectious Disease/Epidemiology
  • Medical or Health Care Field.